Fluidigm Corp (FLDM):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Fluidigm Corp (FLDM) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7326
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:53
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Fluidigm Corp (Fluidigm), formerly Mycometrix Corp, develops, manufactures, and markets life science analytical and preparatory systems for mass cytometry, high-throughput genomics, and single-cell genomics markets. The company offers analytical systems and instruments, preparatory instruments, integrated fluidic circuits and assays and reagents to clinical research laboratories; academic institutions; biopharmaceutical, biotechnology, and agricultural biotechnology companies; and contract research organizations worldwide. Fluidigm manufactures its products through multi-layer soft lithography technology and CyTOF technology, among others. The company distributes its systems through direct sales force and support organizations across North America, Europe and Asia-Pacific; and also through a network of distributors across Europe, Latin America, the Middle East and Asia-Pacific. Fluidigm is headquartered in South San Francisco, California, the US.

Fluidigm Corp (FLDM) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Fluidigm Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Fluidigm Corp, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Fluidigm Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Fluidigm Corp, Medical Equipment, Deals By Market, 2012 to YTD 2018 9
Fluidigm Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Fluidigm Corp, Medical Equipment, Deal Details 11
Venture Financing 11
Fluidigm Raises USD76.80 Million in Venture Financing 11
Partnerships 12
Fluidigm Enters into Licensing Agreement with Baylor Genetics Labs 12
Fluidigm Enters into Co-Marketing Agreement with Visiopharm 13
Fluidigm and Ascendas Genomics Enter into Partnership 14
Fluidigm Enters into Distribution Agreement with GenomOncology 15
OpGen Enters into Co-Development Agreement with Fluidigm 16
Fluidigm Enters Into Co-Marketing Agreement With Olink Bioscience For Protein Biomarkers 17
Fluidigm Enters Into Co-Development Agreement With DKMS For High Throughput HLA Typing System 19
Equity Offering 20
Fluidigm Raises USD30 Million in Public Offering of Shares 20
Fluidigm Completes Public Offering Of Common Stock For US$60 Million 21
Debt Offering 23
Fluidigm Completes Public Offering Of Notes Due 2034 For US$201.3 Million 23
Acquisition 25
Fluidigm Completes Acquisition Of DVS Sciences For US$207.5 Million 25
Fluidigm Corp – Key Competitors 27
Fluidigm Corp – Key Employees 28
Fluidigm Corp – Locations And Subsidiaries 29
Head Office 29
Other Locations & Subsidiaries 29
Recent Developments 30
Financial Announcements 30
Aug 02, 2018: Fluidigm announces second quarter 2018 financial results 30
May 03, 2018: Fluidigm Announces First Quarter Financial Results and Operational Progress 32
Feb 08, 2018: Fluidigm Announces Fourth Quarter and Full Year 2017 Financial Results and Operational Progress 34
Nov 02, 2017: Fluidigm Announces Third Quarter Financial Results and Operational Progress 36
Aug 03, 2017: Fluidigm Announces Second Quarter Financial Results and Operational Progress 38
May 04, 2017: Fluidigm Announces First Quarter Financial Results 40
Feb 08, 2017: Fluidigm Announces Q4 And Full Year 2016 Financial Results 43
Jan 09, 2017: Fluidigm Announces Preliminary Revenue For The Fourth Quarter And Full Year 45
Corporate Communications 46
Jun 26, 2018: Fluidigm Appoints David King As Vice President, Research and Development, Genomics 46
Apr 23, 2018: Fluidigm Appoints Brad Kreger As Senior Vice President, Global Operations 47
Mar 27, 2017: Nicolas Barthelemy and Carlos Paya Join Fluidigm Board of Directors 48
Product News 49
Aug 09, 2018: Fluidigm to host 2nd annual imaging mass cytometry user group meeting 49
Apr 13, 2018: Fluidigm Introduces High-Parameter Maxpar Immune Monitoring Panel for Translational and Clinical Research 50
Oct 24, 2017: Fluidigm Introduces Imaging Mass Cytometry System for Highly Multiplexed Protein Detection in Tissues 51
Oct 18, 2017: Fluidigm to Unveil High-Parameter Tissue Imaging System 52
Appendix 53
Methodology 53
About GlobalData 53
Contact Us 53
Disclaimer 53

List of Tables
Fluidigm Corp, Medical Equipment, Key Facts, 2017 2
Fluidigm Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Fluidigm Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Fluidigm Corp, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Fluidigm Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Fluidigm Corp, Deals By Market, 2012 to YTD 2018 9
Fluidigm Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Fluidigm Raises USD76.80 Million in Venture Financing 11
Fluidigm Enters into Licensing Agreement with Baylor Genetics Labs 12
Fluidigm Enters into Co-Marketing Agreement with Visiopharm 13
Fluidigm and Ascendas Genomics Enter into Partnership 14
Fluidigm Enters into Distribution Agreement with GenomOncology 15
OpGen Enters into Co-Development Agreement with Fluidigm 16
Fluidigm Enters Into Co-Marketing Agreement With Olink Bioscience For Protein Biomarkers 17
Fluidigm Enters Into Co-Development Agreement With DKMS For High Throughput HLA Typing System 19
Fluidigm Raises USD30 Million in Public Offering of Shares 20
Fluidigm Completes Public Offering Of Common Stock For US$60 Million 21
Fluidigm Completes Public Offering Of Notes Due 2034 For US$201.3 Million 23
Fluidigm Completes Acquisition Of DVS Sciences For US$207.5 Million 25
Fluidigm Corp, Key Competitors 27
Fluidigm Corp, Key Employees 28
Fluidigm Corp, Subsidiaries 29

List of Figures
Fluidigm Corp, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Fluidigm Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Fluidigm Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Fluidigm Corp, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Fluidigm Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Fluidigm Corp, Medical Equipment, Deals by Type, 2012 to YTD 2018 7
Fluidigm Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Fluidigm Corp, Medical Equipment, Deals by Market, 2012 to YTD 2018 9

★海外企業調査レポート[Fluidigm Corp (FLDM):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • NuVasive Inc (NUVA):企業の財務・戦略的SWOT分析
    NuVasive Inc (NUVA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Andorra Banc Agricol Reig SA:企業の戦略・SWOT・財務情報
    Andorra Banc Agricol Reig SA - Strategy, SWOT and Corporate Finance Report Summary Andorra Banc Agricol Reig SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Progenics Pharmaceuticals Inc (PGNX):製薬・医療:M&Aディール及び事業提携情報
    Summary Progenics Pharmaceuticals Inc (Progenics) is a late-stage biopharmaceutical company that focuses on developing medicines and products for the treatment of cancer and related conditions. Its only commercial product, Relistor, is used for the treatment of opioid-induced constipation. The compa …
  • UGE International Ltd (UGE):企業の財務・戦略的SWOT分析
    Summary UGE International Ltd (UGE), formerly Way Ventures Inc, is a renewable energy company that operates through wind, solar, solar-wind technologies. The company offers products such as electronics and accessories, wind turbines, solar panels, energy storage systems, mounting system, electronics …
  • Damen Shipyards Group:企業の戦略・SWOT・財務情報
    Damen Shipyards Group - Strategy, SWOT and Corporate Finance Report Summary Damen Shipyards Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Aequus Pharmaceuticals Inc (AQS):医療機器:M&Aディール及び事業提携情報
    Summary Aequus Pharmaceuticals Inc (Aequus Pharmaceuticals) is a drug discovery and development company that develops differentiated drugs. The company’s pipeline products include AQS301, AQS302 and AQS303. Its commercial pipeline comprises ophthalmology products and transplant products. Aequus Phar …
  • Axikin Pharmaceuticals Inc-製薬・医療分野:企業M&A・提携分析
    Summary Axikin Pharmaceuticals Inc (Axikin) is a biopharmaceutical company that develops small molecule therapeutics for respiratory disorders. The company offers pre-clinical and research programs with small molecule therapeutics for applications in asthma, chronic obstructive pulmonary disease, in …
  • If P&C Insurance AS:企業の戦略・SWOT・財務分析
    If P&C Insurance AS - Strategy, SWOT and Corporate Finance Report Summary If P&C Insurance AS - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Chemetall GmbH:企業の戦略的SWOT分析
    Chemetall GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Kiwibank Limited:企業の戦略・SWOT・財務情報
    Kiwibank Limited - Strategy, SWOT and Corporate Finance Report Summary Kiwibank Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Tenaska Inc:企業の発電所・SWOT分析2018
    Tenaska Inc - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (execut …
  • Bossard Holding AG:企業の戦略・SWOT・財務情報
    Bossard Holding AG - Strategy, SWOT and Corporate Finance Report Summary Bossard Holding AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Pakistan Refinery Ltd (PRL):石油・ガス:M&Aディール及び事業提携情報
    Summary Pakistan Refinery Ltd (PRL) is a downstream oil and gas company. It carries out refining, production and supply of refined petroleum products. It operates a hydro skimming refinery, which is designed to process various imported and local crude oil into distilled petroleum products such as fu …
  • C.H. Robinson Worldwide, Inc.:企業の戦略・SWOT・財務情報
    C.H. Robinson Worldwide, Inc. - Strategy, SWOT and Corporate Finance Report Summary C.H. Robinson Worldwide, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • The Hong Kong and China Gas Company Limited:企業の戦略・SWOT・財務情報
    The Hong Kong and China Gas Company Limited - Strategy, SWOT and Corporate Finance Report Summary The Hong Kong and China Gas Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation …
  • Tohoku Electric Power Company, Incorporated:企業の戦略・SWOT・財務情報
    Tohoku Electric Power Company, Incorporated - Strategy, SWOT and Corporate Finance Report Summary Tohoku Electric Power Company, Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation …
  • Cenveo, Inc.:企業の戦略的SWOT分析
    Cenveo, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Colas SA (RE):企業の財務・戦略的SWOT分析
    Colas SA (RE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pot …
  • Thai Airways International Public Co Ltd:戦略・SWOT・企業財務分析
    Thai Airways International Public Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Thai Airways International Public Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …
  • Axxam SpA-製薬・医療分野:企業M&A・提携分析
    Summary Axxam SpA (Axxam) is a partner research organization that provides drug discovery services. The organization offers drug discovery services such as molecular biology, assay development and reagent provision, compound management, hit characterization and profiling and electrophysiology, among …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆